Search research articles
Contact Us
Filters
Showing results (101-110 of 194) with videos related to
Page
of 20
Sort By:
Hematology/Oncology and Stem Cell Therapy
|
July 6, 2011
Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma
Ciprian Tomuleasa, Olga Soritau, Eva Fischer-Fodor, et al.
International Journal of Nanomedicine
|
March 8, 2013
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
Anamaria Orza, Olga Soriţău, Ciprian Tomuleasa, et al.
Journal of Clinical Medicine
|
January 24, 2020
Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
Carla Griesel, Minodora Desmirean, Tonya Esterhuizen, et al.
Annals of Hematology
|
April 23, 2015
MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation
Ciprian Tomuleasa, Shigeo Fuji, Andrei Cucuianu, et al.
Journal of Personalized Medicine
|
December 27, 2022
COVID-19 Impact on Chronic Myeloid Leukemia Patients
Dana Raluca Arbore, Simona Maria Galdean, Delia Dima, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|
January 20, 2017
Transthoracic ultrasonography for the immunocompromised patient. A pilot project that introduces transthoracic ultrasonography for the follow-up of hematological patients in Romania
Ioana Frinc, Petru Ilies, Florin Zaharie, et al.
ACS Applied Materials & Interfaces
|
June 3, 2017
Antibody Conjugated, Raman Tagged Hollow Gold-Silver Nanospheres for Specific Targeting and Multimodal Dark-Field/SERS/Two Photon-FLIM Imaging of CD19(+) B Lymphoblasts
Timea Nagy-Simon, Andra-Sorina Tatar, Ana-Maria Craciun, et al.
Journal of Clinical Medicine
|
September 11, 2020
Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
Catalin Constantinescu, Sergiu Pasca, Alina-Andreea Zimta, et al.
Molecules (Basel, Switzerland)
|
March 31, 2017
Novel Palladium(II) Complexes that Influence Prominin-1/CD133 Expression and Stem Cell Factor Release in Tumor Cells
Eva Fischer-Fodor, Roman Mikláš, Lucia Rišiaňová, et al.
Cell Death Discovery
|
November 17, 2024
Therapeutic advances in the targeting of ROR1 in hematological cancers
Adrian-Bogdan Tigu, Raluca Munteanu, Cristian Moldovan, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 194) with videos related to
Sort By:
Page
of 20
Hematology/Oncology and Stem Cell Therapy
|
July 6, 2011
Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma
Ciprian Tomuleasa, Olga Soritau, Eva Fischer-Fodor, et al.
International Journal of Nanomedicine
|
March 8, 2013
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
Anamaria Orza, Olga Soriţău, Ciprian Tomuleasa, et al.
Journal of Clinical Medicine
|
January 24, 2020
Differential Diagnosis of Malignant Lymphadenopathy Using Flow Cytometry on Fine Needle Aspirate: Report on 269 Cases
Carla Griesel, Minodora Desmirean, Tonya Esterhuizen, et al.
Annals of Hematology
|
April 23, 2015
MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation
Ciprian Tomuleasa, Shigeo Fuji, Andrei Cucuianu, et al.
Journal of Personalized Medicine
|
December 27, 2022
COVID-19 Impact on Chronic Myeloid Leukemia Patients
Dana Raluca Arbore, Simona Maria Galdean, Delia Dima, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|
January 20, 2017
Transthoracic ultrasonography for the immunocompromised patient. A pilot project that introduces transthoracic ultrasonography for the follow-up of hematological patients in Romania
Ioana Frinc, Petru Ilies, Florin Zaharie, et al.
ACS Applied Materials & Interfaces
|
June 3, 2017
Antibody Conjugated, Raman Tagged Hollow Gold-Silver Nanospheres for Specific Targeting and Multimodal Dark-Field/SERS/Two Photon-FLIM Imaging of CD19(+) B Lymphoblasts
Timea Nagy-Simon, Andra-Sorina Tatar, Ana-Maria Craciun, et al.
Journal of Clinical Medicine
|
September 11, 2020
Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies
Catalin Constantinescu, Sergiu Pasca, Alina-Andreea Zimta, et al.
Molecules (Basel, Switzerland)
|
March 31, 2017
Novel Palladium(II) Complexes that Influence Prominin-1/CD133 Expression and Stem Cell Factor Release in Tumor Cells
Eva Fischer-Fodor, Roman Mikláš, Lucia Rišiaňová, et al.
Cell Death Discovery
|
November 17, 2024
Therapeutic advances in the targeting of ROR1 in hematological cancers
Adrian-Bogdan Tigu, Raluca Munteanu, Cristian Moldovan, et al.
Page
of 20